In this Issue:
EASL recommendations on treatment of hepatitis C
Liraglutide for NASH
Statin use in HCV compensated cirrhosis
CVD and mortality in non-alcoholic fatty liver disease
Severe comorbidities and alcohol use in chronic HCV
GWAS for alcohol-related cirrhosis
Obeticholic acid for NASH
Ledipasvir/sofosbuvir/ribavirin for HCV in liver disease patients
Rifaximin + propranolol and portal pressures
Please login below to download this issue (PDF)